Profile: Harriet Fear – CEO, One Nucleus
Harriet joined One Nucleus (formerly ERBI) as CEO in February 2009. She previously worked as a Diplomat with the British Foreign Office for 21 years serving in over 17 countries around the globe. Half her career was spent in the commercial field, latterly heading UK Trade & Investments national life sciences trade team for over 5 years.
During her varied Foreign Office career she was Deputy Ambassador three times, Private Secretary to the Minister for Europe, led an evacuation of Brits out of the Congo and worked in Khymer Rouge territory with Scotland Yard on a hostage crisis. She now enjoys a calmer life in the UK!
She was attracted to the role at One Nucleus because she wanted to spend time helping companies maximise their competitiveness and to lead a team which already had an excellent reputation. Since her arrival at One Nucleus, the company has redefined its membership (now life science and healthcare, not only biotech), formed strong and strategic relations with like minded US counterparts for the benefit of members and merged ERBI with London Biotechnology Network to enhance the offer to members and create a stronger critical mass on the international stage.
One Nucleus is the largest membership organisation in Europe. A not-for-profit private company, it has over 450 members including pharmaceutical, biotech, medical device and diagnostic companies and associated technical and commercial service providers.
The One Nucleus mission is to maximise the global competitiveness of its members. For their science and technology-based members, this means being global leaders in the research, development and commercialisation of healthcare innovations that radically improve the quality of people’s lives around the world. For their business and professional services members, it means delivering exceptional services that significantly enhance the business performance of their clients.